With NO protocol written up and further study needed, this solved nothing to help survivors recover.
Comparison of Robotics, FES, and Motor Learning Methods for Treatment of Persistent Upper Extremity Dysfunction after Stroke: a Randomized Controlled Trial
Abstract
Objective:
To compare response to upper limb treatment using robotics (ROB) + motor learning (ML) vs. functional electrical stimulation (FES) + ML vs. ML alone, according to a measure of complex functional everyday tasks for chronic, severely impaired stroke survivors.
Design:
single-blind, randomized trial.
Setting
: Clinical research lab, Medical Center.
Participants:
39 enrolled subjects, >1 year post single stroke (attrition rate=10%; 35 completed the study). No adverse effects.
Interventions:
All groups received treatment 5 days/week, 5hrs/day (60 sessions), with unique treatment as follows: ML alone (n=11), 5hrs/day partial and whole task practice of complex functional tasks; ROB+ML (n=12), 3.5hrs/day ML and 1.5hrs/day shoulder/elbow robotics; FES+ML (n=12), 3.5hrs/day ML and 1.5hrs/day FES wrist/hand coordination training.
Main Outcome Measures
: Primary measure: Arm Motor Ability Test (AMAT), 13 complex
functional tasks; secondary measure: upper limb Fugl-Meyer coordination (FM).
Results:
No significant difference found in treatment response across groups (AMAT (p≥.584) and FM (p≥.590)). All three treatment groups demonstrated clinically and statistically significant
improvement in response to treatment (AMAT and FM, p≤.009). A group treatment paradigm of 1:3 (therapist:patient) ratio proved feasible for provision of the intensive treatment.
Conclusions:
Severely impaired stroke survivors with persistent (>1yr) upper extremity dysfunction can make clinically and statistically significant gains in coordination and functional task performance, in response to ROB+ML, FES+ML, and ML alone, in an intensive and long duration intervention, and no group difference was found. Additional study is warranted to determine the effectiveness of these methods in the clinical setting.
No comments:
Post a Comment